The new age clinical research sites are becoming increasingly selective about which sponsor/CRO they would want to work with on industry-sponsored clinical trials. One selection criterion that sites stringently look... read more →
The International Council for Harmonization’s addendum to the ICH E6 Guideline for Good Clinical Practice (ICH E6 R2) and EU regulation 536/2014 strongly advocates the adoption of risk-based monitoring (RBM)... read more →
